医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Nihon Kohden Achieves Great Place to Work® Status for Fourth Consecutive Year

2019年08月01日 PM09:05
このエントリーをはてなブックマークに追加


 

IRVINE, Calif.

Nihon Kohden, a U.S. market leader in precision medical products and services, today announced that it has been named a great workplace for the fourth year in a row by the Great Place to Work® Institute, the global authority on high-trust, high-performance workplace cultures. The recertification comes as the company continues to experience industry-leading growth in patient monitoring while maintaining its position as a trailblazer in neurology.

“We believe that being named a Great Place to Work is one of the highest honors we could receive,” said Yasuhiro Yoshitake, president and CEO of Nihon Kohden America. “Because this is based on feedback from employee surveys that are conducted independently by the Great Place to Work Institute, this is an accurate representation of how employees feel about the company and the company’s dedication to its employees. As always, Nihon Kohden is committed to continually improving its culture and ensuring our employees feel valued and rewarded.”

Nihon Kohden’s recertification was based on anonymous feedback from current employees on the employee experience, atmosphere, rewards, pride, communication and leadership. The company’s highest marks were for the sense of pride employees feel in their work, the amount of responsibility and autonomy afforded them to accomplish their jobs, and inclusion. A summary of the company’s ratings can be found here.

“In our fourth year of evaluating Nihon Kohden, we have continued to see the organization excel in key areas, including the amount of respect and fairness offered employees, as well as the pride people feel working there and the credibility leadership has in the organization,” said Sarah Lewis-Kulin, vice president of Best Workplace List Research at Great Place to Work. “These attributes foster positive and productive work environments that allow the company to attract talented individuals and maintain its industry-leading position.”

Nihon Kohden is currently seeking new team members for positions in all areas, including network engineering, software engineering, installation, sales, and clinical. For more information, please visit Nihon Kohden Careers.

About Great Place to Work

Great Place to Work is the global authority on high-trust, high-performance workplace cultures. The organization uses proprietary assessment tools, advisory services, and certification programs, including best workplaces lists and workplace reviews, to provide the benchmarks, framework, and expertise needed to create, sustain, and recognize outstanding workplace cultures. Great Place to Work certification gives companies valuable data about the current state of the workplace culture, plus qualifies the organization to compete for 20+ best workplaces lists, produced annually with Fortune. For more information, visit www.greatplacetowork.com.

About Nihon Kohden Corporation

Founded in Japan in 1951, Nihon Kohden is a leading manufacturer, developer and distributor of medical electronic equipment, with subsidiaries in the U.S., Europe and Asia. The company’s products are now used in more than 120 countries, and it is the largest supplier of electroencephalography products worldwide. A pioneer in transformational healthcare technology, Nihon Kohden has envisioned, designed and produced revolutionary devices, such as pulse oximeters, arrhythmia analysis, low-invasive blood volume monitoring and wireless patient monitoring. In the U.S., the company is a trusted source for patient monitoring, sleep assessment, neurology and cardiology instrumentation solutions, and has been rated No. 1 in patient monitoring or telemetry for more than 10 consecutive years (MD Buyline). For more information, visit us.nihonkohden.com.

MD Buyline is a registered service mark of MD Buyline.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190801005279/en/

CONTACT

Julie Johnson

Senior Director, Communications and Public Relations

949-238-4869

Julie_Johnson@nihonkohden.com

同じカテゴリーの記事 

  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024
  • Kolmar Korea Wins Case Against Italian Cosmetics Maker Intercos for Suncare Technology Theft
  • 大手CDMOのPCIファーマ・サービシズが初の包括ESG報告書を発表